Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $398.5200 (5.55%) ($380.7803 - $399.4000) on Tue. Oct. 16, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.88% (three month average) | RSI | 53 | Latest Price | $398.5200(5.55%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.3% a day on average for past five trading days. | Weekly Trend | REGN declines -2.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(61%) XLV(50%) IVW(43%) IWF(43%) QQQ(43%) | Factors Impacting REGN price | REGN will decline at least -0.94% in a week (0% probabilities). VXX(-12%) UUP(-11%) TLT(-7%) VIXM(-4%) IFRA(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.94% (StdDev 1.88%) | Hourly BBV | 0 () | Intraday Trend | 4.5% | | | |
|
1 - 5 Day Possible Target | $380.67(-4.48%) | 5 Day Moving Average | $382.77(4.11%) | 10 Day Moving Average | $388.45(2.59%) | 20 Day Moving Average | $391.14(1.89%) | To recent high | -2.4% | To recent low | 10.1% | Market Cap | $42.255b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |